United States

People: Genomic Health Inc (GHDX.OQ)

GHDX.OQ on NASDAQ Stock Exchange Global Select Market

4:00pm EDT
Change (% chg)

$1.34 (+2.06%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Graham, Ginger 

Ms. Ginger L. Graham serves as Independent Director of the Company. Ms. Graham served as Faculty at Harvard Business School from October 2009 to June 2012 and was Chief Executive Officer of Amylin Pharmaceuticals, Inc., a biopharmaceutical company, from September 2003 to March 2007, and served as Amylin’s President from September 2003 to June 2006. From 1994 to 2003, Ms. Graham held various positions with Guidant Corporation, including Group Chairman, Office of the President, President of the Vascular Intervention Group, and Vice President. From 1979 to 1994, Ms. Graham held various positions with Eli Lilly and Company, including President and Chief Executive Officer of Advanced Cardiovascular Systems, Inc. Ms. Graham currently serves as a director of Clovis Oncology, Inc., Walgreens Boot Alliance, Inc. and a number of privately held companies. Ms. Graham holds a B.S. in Agricultural Economics from the University of Arkansas and an M.B.A. from Harvard University.

Basic Compensation

Total Annual Compensation, USD 9,000
Restricted Stock Awards, USD 40,000
Long-Term Incentive Plans, USD --
All Other, USD 132,727
Fiscal Year Total, USD 181,727

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Kimberly Popovits


Gordon Cole


Steven Shak


Phillip Febbo


Laura Kammeyer


Frederic Pla

As Of  30 Dec 2017